Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Boehringer Ingelheim
Farmers Insurance
Accenture
Colorcon
Fish and Richardson
Merck
US Army
Julphar

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,536,150

« Back to Dashboard

Which drugs does patent 8,536,150 protect, and when does it expire?

Patent 8,536,150 protects LEXISCAN and is included in one NDA.

This patent has four patent family members in three countries.
Summary for Patent: 8,536,150
Title:Methods of myocardial perfusion imaging
Abstract: The present invention provides a method of myocardial perfusion imaging using reduced doses of (1-{9-[(4S,2R,3R,5R)3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopu- rin-2-yl}pyrazol-4-yl)-N-methylcarboxamide.
Inventor(s): Belardinelli; Luiz (Palo Alto, CA), Blackburn; Brent K. (Los Altos, CA), Gao; Zhenhai (San Jose, CA)
Assignee: Gilead Sciences, Inc. (Foster City, CA)
Application Number:13/525,223
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 8,536,150

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Astellas LEXISCAN regadenoson SOLUTION;INTRAVENOUS 022161-001 Apr 10, 2008 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial METHOD OF MYOCARDIAL IMAGING ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,536,150

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,163,057 Methods of myocardial perfusion imaging ➤ Try a Free Trial
7,582,617 Myocardial perfusion imaging method ➤ Try a Free Trial
8,071,566 Methods of coronary imaging ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 8,536,150

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 3866501 ➤ Try a Free Trial
Canada 2439222 ➤ Try a Free Trial
Canada 2671940 ➤ Try a Free Trial
World Intellectual Property Organization (WIPO) 0162979 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Queensland Health
Federal Trade Commission
Healthtrust
Chubb
Express Scripts
Dow
Cerilliant
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.